Compare

    Two terms, side by side

    Pick any two terms to see definitions, context, pitfalls, and sources in parallel.

    Curated comparison tables

    In-depth, attribute-by-attribute tables for the most common MedTech term pairs. Each row is sourced from the linked term pages.

    Software & AI

    Synthetic Data

    In one line
    Artificially generated data used to augment training, validation, or stress-testing of medical AI.
    Definition
    Synthetic data is generated by simulators, generative models, or rule-based systems. Used to balance underrepresented subgroups, model rare events, or substitute for sensitive data - but introduces realism, leakage, and bias-amplification risks. Regulators generally treat synthetic data as supplementary: it can help with training or stress testing, but performance claims should rest on real-world clinical data. FDA's Office of Science and Engineering Laboratories has published research on synthetic data and in silico testing. If synthetic data is used, manufacturers should document how it was generated, how realistic it is and how it could affect model behavior.
    Why it matters
    FDA has explicitly noted both the promise and the limits of synthetic data for training and validation; transparent reporting is expected.
    Common pitfalls
    • •A common pitfall is generating synthetic data that fails to capture the true underlying statistical properties or rare events accurately, leading to models that perform poorly in real-world scenarios.
    • •Another mistake is using synthetic data without sufficient transparency regarding its generation methods, assumptions, and validation, which can hinder regulatory review.
    • •Failing to address potential biases amplified during synthetic data generation is a significant pitfall, as it can perpetuate or exacerbate inequities in AI/ML-enabled medical devices.
    • •Over-reliance on synthetic data without subsequent validation against real-world data can lead to a false sense of security regarding model performance and safety.
    • •A pitfall is not adequately assessing the impact of synthetic data on the overall risk management strategy of a medical device, especially regarding safety and effectiveness.
    Open full page
    Select term B to compare.

    Why compare MedTech terms side by side?

    MedTech terminology is full of pairs that look interchangeable but carry very different regulatory, clinical, and commercial consequences. Picking the wrong framework, pathway, or standard early in a project can add months to a submission, invalidate clinical evidence, or trigger an audit finding. Side-by-side comparison is the fastest way to surface those differences before they become costly mistakes.

    Each comparison on this page pulls from the same vendor-neutral, sourced definitions used throughout the MedTech Terms glossary. You see the one-line summary, the formal definition, why it matters in practice, common pitfalls, and the primary sources (FDA guidance, EU MDR/IVDR articles, ISO/IEC standards, MDCG documents, IMDRF principles) that back each entry. That makes the comparison defensible in regulatory strategy memos, design reviews, and submission narratives.

    Common comparison patterns

    How to use this tool

    Pick term A and term B from the dropdowns, or click a preset above. The URL updates with both slugs so you can bookmark or share the exact comparison with a colleague, a notified body reviewer, or your regulatory consultant. Click Open full page on either side for the complete entry, including FAQs, related terms, and the full citation list. If you are not sure which term to start with, browse the Categories view or the A-Z index.

    MedTech Terms is a vendor-neutral community resource sponsored by Blue Goat Cyber. Definitions are written for educational use and are not legal or regulatory advice.